Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. - Wikidata - awgldk - TriplyDB

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

http://www.wikidata.org/entity/Q34623015

about

Current investigational drugs for major depression Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs The role of the brown adipose tissue in β3-adrenergic receptor activation-induced sleep, metabolic and feeding responses Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors.Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.A beta3-adrenergic-leptin-melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress.Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature.Role of β-adrenoceptors in glucose uptake in astrocytes using β-adrenoceptor knockout mice.Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats The novel object recognition memory: neurobiology, test procedure, and its modifications.β1-adrenoceptor activation is required for ethanol enhancement of lateral paracapsular GABAergic synapses in the rat basolateral amygdala Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type Chemogenetic and Optogenetic Activation of Gαs Signaling in the Basolateral Amygdala Induces Acute and Social Anxiety-Like States Effect of β3 adrenoceptor activation in the basolateral amygdala on ethanol seeking behaviors.β(3)-Adrenoceptor ligand development history through patent review.Rescue of impaired sociability and anxiety-like behavior in adult cacna1c-deficient mice by pharmacologically targeting eIF2α.Locus Ceruleus Norepinephrine Release: A Central Regulator of CNS Spatio-Temporal Activation?β3-Adrenergic receptors, adipokines and neuroendocrine activation during stress induced by repeated immune challenge in male and female rats.Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of beta 3 adrenoceptor activation.Acute effect of Copaifera reticulata Ducke copaiba oil in rats tested in the elevated plus-maze: an ethological analysis.Tissue functions mediated by beta(3)-adrenoceptors-findings and challenges.Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice.CNS β3-adrenergic receptor activation regulates feeding behavior, white fat browning, and body weight.Genetic characterization of physical activity behaviours in university students enrolled in kinesiology degree programs.Role of physical exercise and omega-3 fatty acids on depressive illness in the elderly.Models of depression: unpredictable chronic mild stress in mice.Involvement of β3-adrenergic receptors in the control of food intake in rats.Vulnerability in early life to changes in the rearing environment plays a crucial role in the aetiopathology of psychiatric disorders.Specificity evaluation of antibodies against human β3-adrenoceptors.Hippocampal protein kinase D1 is necessary for DHPG-induced learning and memory impairments in rats.Adrenergic receptor β3 is involved in the memory consolidation process in mice

P2860

Q28244223-34CEEFB5-E5FD-45D9-9167-DD41CCE7D532 Q28305100-20BFB9AE-62B4-49FE-B0EC-A660ED950CFC Q33680861-C9CBF2CE-476E-498C-AD93-2A71DFCB0508 Q33725000-B66768D7-3359-452C-9A50-2EE211F23CA8 Q33756416-D0A7FD00-8759-4EA5-8D13-736B6ED9E8C6 Q33838174-38915EC6-13FE-41E2-9C69-077A8D36A5F4 Q33843688-37AFB5C2-A74A-4570-A3FE-E842008F6DB7 Q34253463-167AD834-2C5B-44E3-ADBC-36FF2C554666 Q34588659-BE66F316-ED2F-49F8-9EC9-91EE7C215DDB Q34837697-22924A2E-7500-465B-B7A2-63D2FA2E2606 Q35119719-4DB2D972-4866-45F3-BAB0-8807738FFBBC Q35904451-89A260FF-1FA8-4AFA-965D-0F3D73A8A8A2 Q36335513-382E0DA6-01CF-41EE-9194-6EE55D5015D5 Q36809746-D819D581-9DF1-4FA8-8189-50CDCED3FF16 Q37006297-AFCA3FDC-5330-4DA8-BD62-CE99F6F53868 Q37424549-FD27EA68-B9BB-43F3-B728-929A1AAB8850 Q37853580-8B2CE016-9A4B-41F3-9773-C8136FC4CC24 Q38674431-7CD48350-086F-4ACB-B741-CB35D136E7CD Q39402128-16653B68-4B65-4708-B84A-B6CAB385AFEA Q40249591-3E207410-9C14-4FC4-92A1-F8F9B0C75213 Q42055845-5F9A074E-969C-4CE2-9589-154C3984EE33 Q42631578-4E4E7744-F41E-42EE-994A-998745DF74D2 Q42732323-62EDC4A7-D96E-455D-8367-EB4AA9E0F7ED Q44021367-29ED7078-9393-4F34-9D01-D4A6CC8817AB Q47207949-78793A24-F05D-45BC-8B83-047980A0ABEC Q47442358-597AD03F-F41D-4540-8014-C98A27C5F9C8 Q47623310-4B507AC9-C093-4F37-A4B4-F787EE50D3A7 Q48464942-13A491EE-0126-4399-88BD-EB9E0DE12AC6 Q50606823-89E27A3F-0811-488C-A2B8-3E40B9B5A60A Q50662915-CA6C2D2B-ABAE-4F2A-B9EB-ECFD4483A839 Q51758470-7FDD6B30-600D-4BBD-AB8C-EF6BFECD2954 Q54118045-305BC502-85B8-4116-882A-100FF2C93523 Q58799175-2442727C-8348-464E-B767-B1926BB3D736

P2860

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

http://www.wikidata.org/entity/Q34623015

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@ast

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@en

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@nl

type

label

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@ast

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@en

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@nl

prefLabel

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@ast

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@en

Stimulation of the beta3-Adren ...... iety and depressive disorders.

@nl

P1433

Q34623015-EFC6CD90-EF2C-48B0-94C4-DD2F41CA3F36

P1476

Q34623015-42D6206B-2595-4EE1-8955-A903220871E6

P2093

Q34623015-033AC865-CC53-44A8-A580-1D97F7562680

Q34623015-06D961DF-DE4F-40B1-A16F-4F9F97F4EFA7

Q34623015-260E6DD8-F778-4184-A868-265919AC34D2

Q34623015-33CE6DA6-C15C-42E4-A0A8-5A90DAF19F52

Q34623015-53F6DDD3-9859-4621-A80B-2E90E82B8F69

Q34623015-5D051D56-5F11-45C9-B542-358D61C2F852

Q34623015-72A5DCC4-E0C8-4FC6-AFC7-0075DD434888

Q34623015-7B0FDA74-E4B2-4352-B500-F47EE4A0703A

Q34623015-7EB55955-431F-402D-9A6D-118EB5BFA297

Q34623015-A3235929-3A50-4E6B-B4CE-AA7CF24316A0

P2860

Q34623015-02A8FA1B-615F-4F4D-B800-935E0D59A56E

Q34623015-04C4311A-B756-40EF-AECC-3C1BA37BC5F1

Q34623015-0A352A23-DC4D-4B63-9649-46514E7CC731

Q34623015-15D9A11E-4085-4BCB-BBA9-61748491338A

Q34623015-1677877F-B2E4-43A4-B9F4-E7EF3B00D8DE

Q34623015-182DDBBB-212B-46E7-8EC0-55D9E6A3ED4F

Q34623015-1D084A7B-A9C9-43F2-8EA0-D6F7F7C01D1E

Q34623015-203E6E54-D2B0-49BE-9547-486E789BC745

Q34623015-231BB658-B109-463A-8A2E-93FE0030BCC1

Q34623015-34989615-A049-4F0A-9051-F9DBFEE07967

P2888

Q34623015-C87D251E-865F-4E7F-83DD-7165E399D9A9

P304

Q34623015-DF51A9E1-087B-4FF2-A906-9DF45962227C

P31

Q34623015-0DF6900C-3189-477B-8AEF-1DD80030363F

P356

Q34623015-6E33AAF2-7CA0-41ED-9534-F82A8B3DE77C

P407

Q34623015-D0A88DF3-62FD-4DD4-AC3C-20C13E2E2118

P433

Q34623015-138D5867-A1EE-44DC-B4CD-3BEA08DF511D

P478

Q34623015-06BBCD69-F3E4-436E-B77B-3A42698B6ABA

P50

Q34623015-8377B0F8-00CC-4354-A4E1-ED8556B35E9F

P577

Q34623015-85EAC556-1E44-408A-8A5C-210DBAFA6C30

P5875

Q34623015-E2D68083-4187-4A61-95CE-D91A34B43853

P6179

Q34623015-D29221F1-3F88-4547-AD2E-75D32CF0B416

P698

Q34623015-BEDC7056-3892-4BF3-A8EC-33CD5CA8679F

P356

P1433

Neuropsychopharmacology

P1476

Stimulation of the beta3-Adren ...... xiety and depressive disorders

@en

P2093

Bernard Scatton

http://www.w3.org/2001/XMLSchema#string

Caroline Cohen

http://www.w3.org/2001/XMLSchema#string

Dominique Françon

http://www.w3.org/2001/XMLSchema#string

Gérard le Fur

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Terranova

http://www.w3.org/2001/XMLSchema#string

Jeanne Stemmelin

http://www.w3.org/2001/XMLSchema#string

Matilde Lopez-Grancha

http://www.w3.org/2001/XMLSchema#string

Michel Decobert

http://www.w3.org/2001/XMLSchema#string

Olivier Bergis

http://www.w3.org/2001/XMLSchema#string

Patrick Avenet

http://www.w3.org/2001/XMLSchema#string

P2860

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils

Depression: a new animal model sensitive to antidepressant treatments

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Developments of a water-maze procedure for studying spatial learning in the rat

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action.

Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome.

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.

Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain.

P2888

P304

574-587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1301424

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6367850

http://www.w3.org/2001/XMLSchema#string

P6179

1011476850

http://www.w3.org/2001/XMLSchema#string

P698

17460614

http://www.w3.org/2001/XMLSchema#string